Phase 2 Intermediate Risk Acute Myeloid Leukemia Clinical Trials
3 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–3 of 3 trials
Recruiting
Phase 2
VA Consolidation in Intermediate-Risk AML
Acute Myeloid LeukemiaConsolidation TherapyIntermediate Risk Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University226 enrolled1 locationNCT07672262
Recruiting
Phase 2
Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML
Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid LeukemiaFLT3 Internal Tandem Duplication Positive+1 more
First Affiliated Hospital of Zhejiang University25 enrolled1 locationNCT07259707
Recruiting
Phase 2
Study of VA Combined With HAAG Regimen in Newly Diagnosed Intermediate and High-risk AML Patients
High-Risk Acute Myeloid LeukemiaIntermediate Risk Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University60 enrolled1 locationNCT06394011